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Tuesday, February 23, 2010 611ainvasion of hosts and disease initiation and progression. In order to monitor the
pathogen invasion process, most often one mixes a solution containing patho-
gens into a culture of host cells, and then hopes the host cell being monitored is
invaded by a pathogen. These chance encounters have been monitored using
fluorescence microscopy, allowing for example fluorescent effector proteins
to be monitored as they are injected into a host cell (Enninga, Mounier et al.
2005; Schlumberger, Muller et al. 2005). Such ‘‘mix and hope’’ strategies
are simple, direct, and necessary for initial studies. However, they do not pro-
vide a path to obtain large sample sizes, control of timing of pathogen invasion,
or a way to determine how many bacteria are required to defeat host defenses.
We present recent results from using optoelectronic tweezers (OET) (Chiou,
et al. 2005) as a tool for manipulating single pathogenic bacteria, opening
a promising route for controlled initiation of HP interactions. Optoelectronic
trapping uses laser-excited carriers inside a thin film of amorphous or crystal-
line Si to create a non-uniform electric field. These carriers, coupled with an
electric field modulated in the MHz range produces strong field gradients.
The object being trapped is polarized by the electric field, and gradients in
the electric field create a potential well which traps the object. This trapping
is obtained at extremely low optical intensities (<1W/cm^2) and does not require
functionalization of the pathogen in order to facilitate delivery to the host,
opening up novel possibilities for massively parallel studies of HP interactions.
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Human mesenchymal stem cells (hMSCs) express markers of different lineages
when grown on matrices of an elasticity that mimics various tissues of mesen-
chymal origin. Of particular interest to our group is the possibility of using this
approach to drive hMSCs into skeletal muscle lineage for repair of damaged
skeletal muscle. In order to identify and determine the necessary in vitro culture
conditions that will lead to optimal commitment of cells to the muscle lineage
in vivo, we have been developing biophysical techniques to allow stem cell pre-
commitment to a specific lineage prior to implantation in a diseased tissue by
controlling matrix stiffness under in vitro culture conditions. This technology
has led to a highly reproducible approach to optimizing stem cell fate for hu-
man transplantation. The physical nature of a cell’s microenvironment - includ-
ing elasticity of the surrounding tissue - appears to exert a significant influence
on cell morphology, cytoskeleton and gene expression. Numerous gel systems -
particularly polyacrylamide gels - have tunable elasticity that can be adjusted
over several orders of magnitude from extremely soft to stiff, mimicking the
elasticity of a wide range of tissues by controlling the extent of polymer
cross-linking. Here, we use cross-linked polyacrylamide hydrogels that mimic
the true in-vivo muscle-like elasticity (10-15 kPa) to induce hMSCs to differ-
entiate into myoblasts expressing key early markers of muscle differentiation
program (Pax7, myoD). They also fuse to form myotube like structures ex-
pressing late skeletal muscle markers like troponin I in vitro. We have recently
used these committed cells on our in vivo animal models of muscular dystrophy
and successfully demonstrated that they have a very high potential for integrat-
ing into skeletal muscle and rescuing the muscular defects.
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We have developed two single-molecule fluorescence biosensors that can quan-
titatively detect single or multiple transcription factors (TFs) with high sensitiv-
ity and specificity. The first sensor is based onTF-based coincidence of twoDNA
fragments, each containing half of a particular TF binding sequence. In the ab-
sence of the particular transcription factor, the DNA fragments diffuse indepen-
dently. The coincidence is detectable using 2-colour alternating laser excitation
(ALEX) spectroscopy using either solution or surface-based approaches.
We have detected a single transcription factor (lactose repressor - lacR) at a con-
centration of 100pM without the need for amplification steps. Further we can
detect TFs in a quantitative manner using a simple kinetic model, without
the need for a calibration curve. Using an inducible plasmid for catabolite
activator protein (CAP), we show quantitative detection of changes in gene
expression in bacterial cell lysates over time.
We extend this first sensor to simultaneously detect two transcription factors
(lacR and CAP) in the same solution. Two assays were designed to implementtwo basic Boolean logic operators (AND and OR). We demonstrate correct
functioning of these operators using solution and surface-based approaches
with nM TF concentrations. These operators can be cascaded to form arbitrarily
complex intelligent sensing assays for true multiplexed detection of several TFs
in one experiment.
The second sensor is based on the common phenomenon of TF-induced DNA
bending. The design is uni-molecular with a donor-acceptor pair in close prox-
imity and a binding site for the TF of interest. On binding of the TF (CAP), the
DNA is bent, increasing the donor-acceptor distance. This can be detected via
a change in FRET (Fo¨rster Resonance Energy Transfer) in a quantitative man-
ner. Current investigations are focused on using this sensor for TF detection in
cell lysates and in-vivo.
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Endothelial cells (EC) are integral to the characteristically dense vasculature of
pancreatic islets. This vasculature enables accurate blood-glucose sensing and
rapid secretion of insulin into the blood stream. It also provides pro-survival
hemodynamic signals to EC. How EC and beta cells interact to affect glucose
stimulated insulin response is an actively debated topic. However, long-term
studies in the ex vivo tissue are limited by the loss of EC over a period of
days in traditional culture. We postulate that the EC die in part from an absence
of the shear and media exchange provided by hemodynamic fluid flow. To test
the role of hemodynamic forces on EC, we created a microfluidic device capa-
ble of supplying a range of fluid flow to ex vivo islets. Our protocol controls
temperature, pH and bubble formation using two hot plates and a syringe
pump for long-term desk top experimentation. Using this microfluidic device
with immunofluorescence microscopy, we examined the morphological re-
sponse of islet-EC to a variety of flow rates for 24 and 48 hours. Our results
show more than twice the average percent area and connectivity of EC in islets
treated in the device as compared to no-flow controls stored in traditional cell
culture. Using this device with varying media viscosity, we determined that the
differences in morphology are due to media exchange and not shear-activated
survival. As well, we are currently evaluating the effect of fluid flow on beta
cell survival by ensuring normal glucose stimulated calcium and insulin re-
sponse. Overall, our data indicates that flow in a microfluidic device provides
a reliable co-culture environment enabling the long-term study of cell biology
in the pancreatic islet.
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Ion channels are crucial physiologically, involved in nearly all biological pro-
cesses. Their many roles make them important drug targets as well as targets to
avoid, as for drug safety screening (e.g. the hERG channel). Patch clamp pro-
vides the highest quality measurements of ion channel function and is used by
the pharmaceutical industry to test drug interactions with ion channels, but has
poor cost and throughput performance. As an alternative ion channel measure-
ment platform, artificial lipid bilayers are well established to provide a highly
controllable environment capable of measurement at the single molecule level,
although they also suffer from their own technological shortcomings. Previ-
ously, we developed an artificial lipid bilayer platform which is capable of ship-
ping and indefinite storage. Here we present the continued technological devel-
opment of this system which has resulted in faster bilayer formation times and
the ability to package, store, and ship ion channels with the bilayer chip. We
have also begun to integrate array chip designs with automated and high
throughput solution manipulation and ion channel measurement hardware, ad-
vancing this platform closer to operator-free involvement and low cost high
throughput cell-free electrophysiology.
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Third-generation DNA sequencing technologies are expected to transform bio-
medical research and health care. Although powerful single-molecule DNA
